嘉应制药：上半年净利润2008.26万元，同比增长254.33%

Group 1 - The core viewpoint of the article highlights that Jiaying Pharmaceutical (002198) reported its 2025 semi-annual results, showing a revenue of 199 million yuan, which represents a year-on-year growth of 10.4% [1] - The company achieved a net profit attributable to shareholders of 20.08 million yuan, marking a significant year-on-year increase of 254.33% [1] - Basic earnings per share for the company stood at 0.0396 yuan [1]